Pictet Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.07M | Buy |
348,349
+33,507
| +11% | +$584K | 0.01% | 755 |
|
|
2025
Q1 | $7.62M | Sell |
314,842
-33,012
| -9% | -$799K | 0.01% | 724 |
|
|
2024
Q4 | $11.1M | Buy |
347,854
+49,901
| +17% | +$1.59M | 0.01% | 635 |
|
|
2024
Q3 | $8.77M | Buy |
297,953
+44,905
| +18% | +$1.32M | 0.01% | 686 |
|
|
2024
Q2 | $9.71M | Sell |
253,048
-820,186
| -76% | -$31.5M | 0.01% | 634 |
|
|
2024
Q1 | $63M | Sell |
1,073,234
-271,329
| -20% | -$15.9M | 0.07% | 268 |
|
|
2023
Q4 | $80.5M | Buy |
1,344,563
+610,413
| +83% | +$36.5M | 0.09% | 236 |
|
|
2023
Q3 | $27.9M | Buy |
+734,150
| New | +$27.9M | 0.03% | 389 |
|